Physician profile
William John Moriconi
NPI 1952379224
$532.58
in general payments reported to CMS, 2019-2025
12 companies · $26.18 in 2025
The $26.18 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $65.16 · 2021: $61.55 · 2022: $38.75 · 2025: $26.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $150.20 | 2019-2020 | |
| Fresenius USA Marketing, INC. | $66.78 | 2019-2020 | |
| Vifor Pharma, INC. | $66.25 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $49.63 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $42.00 | 2019 | |
| Opko Pharmaceuticals, LLC | $39.58 | 2019 | |
| US Oncology Corporate, INC. | $38.75 | 2022 | |
| Emd Serono, INC. | $26.18 | 2025 | |
| Merck Sharp & Dohme LLC | $16.27 | 2020 | |
| Shire North American Group INC | $13.95 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Pfizer INC. | $11.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Moriconi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.